Further studies on the immune mechanism of PKM2 are expected to provide more new ideas and targets of drug action for immunotherapy for clinical inflammatory diseases and autoimmune diseases and guide drug development and disease treatment. The gene discussed is PKM; the disease is autoimmune disease.